|
Paul W. Busse joined Faegre & Benson LLP in May of 2001 and is a partner in the firm’s intellectual property group. He is a member of the bars of Minnesota, Illinois, Michigan, the Northern District of Illinois and is admitted to practice before the United States Patent and Trademark Office. Before joining Faegre & Benson LLP, Paul worked for two years with a major pharmaceutical corporation, for four years with a Chicago law firm and nine years with 3M. He has been involved in intellectual property matters including technology transfer and licensing agreements, research and development collaborations, opinions, counseling, U.S. and foreign patent preparation and prosecution, and litigation. Paul was recognized by IP Law & Business magazine in their "Patent Hall of Fame" as one of the nation’s top patent prosecution lawyers. His intellectual property transactional experience includes: Significant research and development collaborations for U.S. Fortune 100 and major international medical device diagnostic and pharmaceutical companies, therapeutic and diagnostic devices, compositions, and cell lines Industrial, academic, and government technology transfer and licensing transactions Medical device and pharmaceutical company mergers and acquisitions Clinical research transactions His U.S. and foreign patent preparation and prosecution experience includes the areas of: Medical and microbial diagnostic devices Immunodiagnostics technology including diagnostics compositions and methods Drug delivery devices and systems Pharmaceutical compositions Methods for microbial production of pharmaceutical agents and biomaterials Recombinant DNA expression of exogenous proteins Isolation and purification of expressed and secreted proteins Central nervous system and viral agents Biocompatible adhesives and sealants Abrasive processes and systems Education B.A., St. Olaf College (1979), cum laude M.S., University of Minnesota (1983) J.D., University of Minnesota (1986) Publications Working with Foreign Associates to Create Effective Worldwide Patent Portfolios Minnesota State Bar Association CLE, 2005 How to Respond to Obviousness Rejections Without Unduly Narrowing Your claims - Chemical and Mechanical Perspectives American Intellectual Property Law Association (AIPLA) 2005 Mid-Winter Institute. Attacking Claim Scope Using § 112, First Paragraph: Invalidity Due to Lack of Enablement.The IP Book, 2003 Developing Technology Transfer Partnerships Trends, Your Business in the Law, January, 2002. | 